Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: An exploratory analysis of a single-blind randomized trial
10.1002/da.20918
Saved in:
Main Authors: | Davis, L.L., Pilkinton, P., Wisniewski, S.R., Trivedi, M.H., Gaynes, B.N., Howland, R.H., Zisook, S., Balasubramani, G.K., Fava, M., Rush, A.J. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110046 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes
by: Davis, L.L., et al.
Published: (2014) -
Adherence to antidepressant combinations and monotherapy for major depressive disorder: A CO-MED report of measurement-based care
by: Warden, D., et al.
Published: (2014) -
Gut microbiome dysbiosis across early Parkinson's disease, REM sleep behavior disorder and their first-degree relatives
by: Huang, Bei, et al.
Published: (2023) -
Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: Results of the NIMH star*D trial
by: Friedman, E.S., et al.
Published: (2014) -
Predictors of attrition during one year of depression treatment: A roadmap to personalized intervention
by: Warden, D., et al.
Published: (2014)